Cingulate News

News

Ticker

CING

ISIN

US17248W3034

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Cingulate Eulerpool News

Cingulate Stock News

Cingulate is being monitored by journalists and investors worldwide. We gather the latest Cingulate news here.

March 20·
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 18·
ChartMill
Which stocks are moving on Wednesday?
March 18·
ChartMill
Here are the top movers in Wednesday's session.
March 18·
ChartMill
Let's uncover which stocks are experiencing notable gaps during today's session.
March 18·
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 18·
Benzinga
Cingulate shares are trading lower after the company reported worse-than-expected Q4 EPS results.
March 18·
Benzinga
Cingulate Q4 EPS $(0.84) Misses $(0.61) Estimate
March 16·
ChartMill
These stocks are moving in today's session
February 17·
Yahoo
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
December 5·
Yahoo
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement
November 20·
Yahoo
Cingulate price target lowered to $16 from $17 at Roth Capital
November 18·
Yahoo
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 3Q25
November 17·
Yahoo
CING: Third Quarter Results
November 13·
Yahoo
Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 10·
Yahoo
Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301
August 25·
Yahoo
CING: NDA Submitted
August 21·
Yahoo
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 2Q25
August 19·
Yahoo
Cingulate Inc. Reports Second Quarter 2025 Financial Results and Provides Recent Highlights
August 15·
Yahoo
Cingulate Provides Management Team Update
July 9·
Yahoo
Cingulate Appoints Nilay Patel as Chief Legal Officer to Support Growth ahead of New Drug Application

Cingulate Stock Press Releases

Cingulate regularly publishes news on the company's website that are relevant for investors.

Cingulate News 2026

This page contains all current news, analysis and press releases for Cingulate stock (CING, ISIN: US17248W3034). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Cingulate.

Cingulate Stock

Cingulate Cingulate Inc is a US-based biopharmaceutical company headquartered in Kansas City, Kansas, that focuses on the development, manufacturing, and commercialization of pharmaceutical products. The firm utilizes its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles designed to improve the lives of patients suffering from commonly diagnosed conditions. The company specifically targets the treatment of attention deficit/hyperactivity disorder (ADHD) through its innovative approach to drug delivery. The firm is currently developing two lead product candidates, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine). These drug candidates both contain three releases of an active pharmaceutical ingredient combined into one small tablet dosage form. By employing this technology, Cingulate Inc aims to provide effective treatment options for ADHD across three core patient segments: children aged 6-12, adolescents aged 13-17, and adults aged 18 and older.